Skip to main content
Log in

A case-control study of recurrent Kawasaki disease using the database of the nationwide surveys in Japan

  • Infectious Diseases
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Abstract

In spite of many reports of recurrent Kawasaki disease, little information about the risk factors associated with recurrence is available. We conducted a case-control study on 150 cases of recurrent Kawasaki disease and 1173 pair-matched controls selected from the database of nationwide surveys of the same disease in Japan. Items observed were: sex, age, use of intravenous gamma globulin, and cardiac sequelae at the first episode. Sex and cardiac sequenlae did not affect the risk of recurrence. One- to 2-year-old chilren were more likely to be affected again than infants (odds ratio [OR]=1.42; 95% confidence interval [CI], 0.94–2.13), and children who were 3 years of age or older were less likely to experience a recurrence than infants (OR=0.59; 95% CI, 0.34–1.02). Intravenous gamma globulin therapy at the first episode increased the risk for recurrence of Kawasaki disease within 12 months (OR=2.66, 95% CI, 1.06–6.66). However, it did not affect recurrences 12 months after the first episode (OR=1.02; 95% CI, 0.53–1.97).

Conclusion

Patients with Kawasaki disease treated with intravenous gamma globulin are 2.66 times as likely to be affected by the disease again within 12 months as those treated without intravenous gamma globulin.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

OR :

odds ratio

CI :

confidence interval

References

  1. Bell DM, Morens DM, Holman RC, Hurwitz ES, Hunter MK (1983) Kawasaki syndrome in the United States. Am J Dis Child 137:211–214

    PubMed  Google Scholar 

  2. Breslow NE, Day NE (1980) Statistical methods in cancer research: vol 1. the analysis of case-control studies. International Agency for Research on Cancer. Lyon, pp 247–279

    Google Scholar 

  3. Chen CY, Wu JR (1989) Relapse of Kawasaki disease: a case report. Kao Hsiung 1 Hsueh Ko Hsueh Tsa Chih 5:189–193

    Google Scholar 

  4. Dean AG, Melish ME, Hicks R, Palumbo NE (1982) An epidemic of Kawasaki syndrome in Hawaii. J Pediatr 100:552–557

    PubMed  Google Scholar 

  5. Furusho K, Kamiya T, Nakano H, et al (1984) High-dose intravenous gammaglobulin for Kawasaki disease. Lancet II:1155–1158

    Google Scholar 

  6. Harada K (1991) Intravenous gammaglobulin treatment in Kawasaki disease. Acta Paediatr Jpn 33:805–810

    PubMed  Google Scholar 

  7. Ichida F, Fatica NS, O'Loughlin JE, et al (1989) Epidemiologic aspects of Kawasaki disease in a Manhattan hospital. Pediatrics 84:235–241

    PubMed  Google Scholar 

  8. Kawasaki T (1967) Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Arerugi 16:178–222

    PubMed  Google Scholar 

  9. Keren G, Passwell J, Cohen BE (1986) Recurrent mucocutaneous lymph node syndrome (Kawasaki disease): a report of three cases. J Med 17:365–371

    PubMed  Google Scholar 

  10. Kikuta H, Matsumoto S, Yanase Y, Kawasaki T, Mizuno F, Osato T (1990) Recurrence of Kawasaki disease and Epstein-Barr virus infection [letter]. J Infect Dis 162:1215

    PubMed  Google Scholar 

  11. Kleinbaum DG, Kupper LL, Morgenstern H (1982) Epidemiologic research Principles and quantitative methods. Van Nostrand Reinhold, New York:194–241

    Google Scholar 

  12. Leung DYM, Burns JC, Newburger JW, Geha RS (1987) Reversal of lymphocyte activation in vivo in the Kawasaki syndrome by intravenous gammaglobulin. J Clin Invest 79:468–472

    PubMed  Google Scholar 

  13. Mason WH, Takahashi M, Schneider T (1993) Recurrence of Kawasaki disease in a large urban cohort in the United States. In: Takahashi M, Taubert K (eds) (1993) Proceedings of the Fourth International Symposium on Kawasaki Disease; 1–4 December 1991, Wailae. Am Heart Assoc. Dallas, pp 21–26

    Google Scholar 

  14. Meade RH, Brandt L (1982) Manifestations of Kawasaki disease in New England outbreak of 1980. J Pediatr 100:558–562

    PubMed  Google Scholar 

  15. Melish ME, Hicks RM, Larson EJ (1976) Mucocutaneous lymph node syndrome in the United States. Am J Dis Child 130:599–607

    PubMed  Google Scholar 

  16. Morens DM, Anderson LJ, Hurwitz ES (1980) National surveillance of Kawasaki disease. Pediatrics 65:21–25

    PubMed  Google Scholar 

  17. Morikawa Y, Ohashi Y, Harada K, et al (1994) A multicenter, randomized, controlled trial of intravenous gamma globulin theray in children with acute Kawasaki disease. Acta Paediatr Jpn 36:347–354

    PubMed  Google Scholar 

  18. Nakamura Y, Fujita Y, Nagai M, et al (1991) Cardiac sequelae of Kawasaki disease in Japan: statistical analysis. Pediatrics 88:1144–1147

    PubMed  Google Scholar 

  19. Nakamura Y, Yanagawa H, Kawasaki T (1992) Mortality among children with Kawasaki disease in Japan. N Engl J Med 326:1246–1249

    PubMed  Google Scholar 

  20. Nakamura Y, Hirose K, Yanagawa H, Kato H, Kawasaki T (1994) Incidence rate of recurrent Kawasaki disease in Japan. Acta Paediatr 84:1061–1064

    Google Scholar 

  21. Newburger JW, Takahashi M, Burns JC, et al (1986) The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med 315:341–347

    PubMed  Google Scholar 

  22. Newburger JW, Takahashi M, Beiser AS, et al (1991) A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med 324:1633–1639

    PubMed  Google Scholar 

  23. Omakoku BA, Chow S, Rao M (1980) Kawasaki disease. NY State J Med 80:1948–1949

    Google Scholar 

  24. Rothman KJ (1986) Modern epidemiology. Little, Brown and Company, Boston, pp 84–89

    Google Scholar 

  25. SAS Institute Inc (1991) SAS technical report P-217 SAS/STAT software: the PHREG procedure: version 6. SAS Institute Inc., Cary

    Google Scholar 

  26. Vargo TA, Huhta JC, Moore WH, Person DA, Edwards MS (1986) Recurrent Kawasaki disease. Pediatr Cardiol 6:199–202

    PubMed  Google Scholar 

  27. Yanagawa H (1993) Epidemiological pictures of Kawasaki disease in Japan. In: Takahashi M, Taubert K (eds) Proceedings of the Fourth International Symposium on Kawasaki Disease: 1–4 December 1991, Wailae. Am Heart Assoc, Dallas, pp 1–5

  28. Yanagawa H, Kawasaki T, Shigematsu I (1987) Nationwide survey on Kawasaki disease in Japan. Pediatrics 80:58–62

    PubMed  Google Scholar 

  29. Yanagawa H, Nakamura Y, Yashiro M, et al (1988) A nationwide incidence survey of Kawasaki disease in 1985–1986 in Japan. J Infect Dis 158:1296–1301

    PubMed  Google Scholar 

  30. Yanagawa H, Yashiro M, Nakamura Y, Kawasaki T, Kato H (1995) Epidemiologic pictures of Kawasaki disease in Japan; from the nationwide incidence survey in 1991 and 1992. Pediatrics 95:475–479

    PubMed  Google Scholar 

  31. Yanagihara R, Todd JK (1980) Acute febrile mucocutaneous lymph node syndrome. Am J Dis Child 134:603–614

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nakamura, Y., Yanagawa, H. A case-control study of recurrent Kawasaki disease using the database of the nationwide surveys in Japan. Eur J Pediatr 155, 303–307 (1996). https://doi.org/10.1007/BF02002717

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02002717

Key words

Navigation